Notably, CHIP variants in genes also related to CLL (including ASXL1, SF3B1, and TP53, Fig. 1b, Supplementary Table 3) accounted for 22% of the CHIP variants. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.